First Heartland Consultants’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $687K | Buy |
8,289
+1,945
| +31% | +$161K | 0.06% | 214 |
|
|
2025
Q1 | $514K | Buy |
6,344
+168
| +3% | +$13.6K | 0.05% | 229 |
|
|
2024
Q4 | $556K | Sell |
6,176
-953
| -13% | -$85.8K | 0.06% | 220 |
|
|
2024
Q3 | $704K | Buy |
7,129
+2,100
| +42% | +$207K | 0.08% | 184 |
|
|
2024
Q2 | $466 | Sell |
5,029
-299
| -6% | -$28 | 0.03% | 271 |
|
|
2024
Q1 | $506K | Buy |
5,328
+2,932
| +122% | +$278K | 0.05% | 250 |
|
|
2023
Q4 | $214K | Sell |
2,396
-411
| -15% | -$36.7K | 0.03% | 342 |
|
|
2023
Q3 | $205K | Buy |
+2,807
| New | +$205K | 0.03% | 359 |
|